Get started
DexCom, Inc.DexCom, Inc.DexCom, Inc.

DexCom, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds
Full chart
Full chart

Compare with DexCom, Inc.



Key stats


Market capitalization
‪33.72 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
34.71
Basic EPS (TTM)
2.59 USD
Net income (FY)
‪836.30 M‬ USD
Revenue (FY)
‪4.66 B‬ USD
Shares float
‪371.11 M‬
Beta (1Y)
0.80

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪11.1 K‬
Change (1Y)
+800+7.77%
Revenue / Employee (1Y)
‪420.00 K‬ USD
Net income / Employee (1Y)
‪75.34 K‬ USD

Company info


Sector
Health Technology
Industry
Medical Specialties
CEO
Jacob S. Leach
Website
dexcom.com
Headquarters
San Diego
Founded
1999
IPO date
Apr 14, 2005
ISIN
US2521311074
CUSIP
252131107
FIGI
BBG000QTF8K1
Identifiers
ISIN US2521311074
CFI code
ESVUFR
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


— YTM
Maturity dateMay 15, 2028
Coupon0.38% (Fixed)

See all DXCM bonds 

ETFs holding the stock


VTI
Vanguard Morningstar Total Stock Market ETF
Weight0.05%
Market value‪1.12 B‬
VOO
Vanguard S&P 500 ETF
Weight0.05%
Market value‪933.60 M‬
VO
Vanguard Morningstar Mid-Cap ETF
Weight0.33%
Market value‪760.04 M‬
QQQ
Invesco QQQ Trust, Series 1
Weight0.15%
Market value‪729.66 M‬
VUG
Vanguard Morningstar Growth ETF
Weight0.12%
Market value‪446.59 M‬
IVV
iShares Core S&P 500 ETF
Weight0.05%
Market value‪442.83 M‬
SPY
SPDR S&P 500 ETF TRUST
Weight0.05%
Market value‪404.47 M‬
VOT
Vanguard Morningstar Mid-Cap Growth ETF
Weight0.79%
Market value‪269.93 M‬
XLV
State Street Health Care Select Sector SPDR ETF
Weight0.56%
Market value‪243.17 M‬
RSP
Invesco S&P 500 Equal Weight ETF
Weight0.23%
Market value‪227.12 M‬
IWP
iShares Russell Midcap Growth ETF
Weight1.00%
Market value‪193.37 M‬

Explore more ETFs 

Frequently asked questions


The current price of DXCM is 89.35 USD — it has increased by 1.61% in the past 24 hours. Watch DexCom, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange DexCom, Inc. stocks are traded under the ticker DXCM.
DXCM stock has risen by 5.55% compared to the previous week, the month change is a −1.05% fall, over the last year DexCom, Inc. has showed a 22.51% increase.
We've gathered analysts' opinions on DexCom, Inc. future price: according to them, DXCM price has a max estimate of 115.00 USD and a min estimate of 82.00 USD. Watch DXCM chart and read a more detailed DexCom, Inc. stock forecast: see what analysts think of DexCom, Inc. and suggest that you do with its stocks.
DXCM reached its all-time high on Nov 18, 2021 with the price of 164.86 USD, and its all-time low was 0.34 USD and was reached on Nov 20, 2008. View more price dynamics on DXCM chart.
See other stocks reaching their highest and lowest prices.
DXCM stock is 2.90% volatile and has beta coefficient of 0.80. Track DexCom, Inc. stock price on the chart and check out the list of the most volatile stocks — is DexCom, Inc. there?
Today DexCom, Inc. has the market capitalization of ‪33.72 B‬, it has increased by 1.33% over the last week.
Yes, you can track DexCom, Inc. financials in yearly and quarterly reports right on TradingView.
DexCom, Inc. is going to release the next earnings report on Oct 22, 2026. Keep track of upcoming events with our Earnings Calendar.
DXCM earnings for the last quarter are 0.70 USD per share, whereas the estimation was 0.61 USD resulting in a 14.59% surprise. The estimated earnings for the next quarter are 0.67 USD per share. See more details about DexCom, Inc. earnings.
DexCom, Inc. revenue for the last quarter amounts to ‪1.31 B‬ USD, despite the estimated figure of ‪1.29 B‬ USD. In the next quarter, revenue is expected to reach ‪1.33 B‬ USD.
DXCM net income for the last quarter is ‪249.10 M‬ USD, while the quarter before that showed ‪199.50 M‬ USD of net income which accounts for 0.00% change. Track more DexCom, Inc. financial stats to get the full picture.
No, DXCM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 20, 2026, the company has ‪11.1 K‬ employees. See our rating of the largest employees — is DexCom, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DexCom, Inc. EBITDA is ‪1.40 B‬ USD, and current EBITDA margin is 24.96%. See more stats in DexCom, Inc. financial statements.
Like other stocks, DXCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DexCom, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DexCom, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DexCom, Inc. stock shows the buy signal. See more of DexCom, Inc. technicals for a more comprehensive analysis.